To view this email as a web page, click here

Today's Rundown

Featured Story

MIT, Novo Nordisk advance oral biologics delivery project

The search for a way to orally administer biologics has led Novo Nordisk to the leopard tortoise. By mimicking the shape of the tortoise’s shell, researchers at MIT and Novo have come up with an oral capsule capable of injecting biologics including Humira into the lining of the stomach.

read more

Top Stories

SpaceX sends drug delivery implants to space station for study

NASA has opened another front in the long-running exploration of drug delivery in space. The latest initiative sees implantable drug delivery devices sent to the International Space Station on a SpaceX resupply mission. 

read more

Amneal lines up FDA Parkinson's filing as pivotal data roll in

Amneal Pharmaceuticals has teed up an attack on the Parkinson’s disease market. With phase 3 data on IPX-203 now in, Amneal is gearing up for a filing for FDA approval of a drug it thinks can unlock the carbidopa/levodopa market.

read more

Sorrento pitches lymphatic delivery for COVID-19 vaccine dose sparing

Developers of the first wave of COVID-19 prophylactics used a range of vaccine technologies but all relied on the same, tried-and-tested vial and syringe administration system. Now, with the pandemic in a new phase, Sorrento Therapeutics has presented preclinical data suggesting delivery to lymph nodes can slash the dose required to generate immunity.

read more

BlueWillow shares early look at data on nasal anthrax vaccine

The U.S. government has continued to seek out new, better anthrax vaccines despite the availability of Emergent BioSolutions’ Biothrax. Now, BlueWillow Biologics, working with Porton Biopharma, has delivered phase 1 data on a nasal vaccine it argues has advantages over other options. 

read more

Resources

Whitepaper: Challenging Tradition: The Argument for Integrated Commercialization to Improve Operational Agility

Today’s economics do not allow manufactures to keep making decisions in an antiquated way. They need to challenge tradition & deliver faster, cheaper, successful launches. Learn how.

Whitepaper: High-yield NK cell culture for allogeneic cell therapy applications

Thermo Fisher Scientific introduces a new NK cell culture medium designed to support feeder-free, high-yield growth for cell therapy applications.

Whitepaper: Challenging Tradition: The Argument for Integrated Commercialization to Improve Operational Agility

Today’s economics do not allow manufactures to keep making decisions in an antiquated way. They need to challenge tradition & deliver faster, cheaper, successful launches. Learn how.

Whitepaper: High-yield NK cell culture for allogeneic cell therapy applications

Thermo Fisher Scientific introduces a new NK cell culture medium designed to support feeder-free, high-yield growth for cell therapy applications.

Whitepaper: Five Trends to Watch in the European Market Access Environment

This white paper provides a concise overview of the trends currently shaping the market access environment in Europe, as well as the implications for biopharma companies.

eBook: Accelerate recruitment with a decentralized clinical trial strategy

Learn how a decentralized clinical trial strategy improves patient recruitment, reduces drop-out rates, and ultimately streamlines the path to the next trial phase.

Whitepaper: How to build a robust packaging strategy for rapid commercialization

Learn how to build a robust packaging strategy and the key technical considerations in packaging design and operational planning to enable rapid commercialization of pharmaceuticals.

Whitepaper: Understanding the CMC regulatory landscape for cell and gene therapy products

Learn how regulations are changing and key considerations for commercializing cell and gene therapies without sacrificing quality.

Whitepaper: Navigating the Digital Transformation Journey

Uncover the real impact of “digital transformation” with practical advice to help you plan your own transformative journey to a harmonized digital ecosystem.

eBook: Get solutions to market faster

Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization.

Content Hub: Process Intensification Resource Center

A one-stop hub for Cytiva resources to support process intesification

Content Hub: Emerging Biotech Resource Center

A one-stop hub for Cytiva resources to support process development and manufacturing of your novel molecule

Content Hub: Remarque Systems Resource Hub

Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. 

Content Hub: How to improve the virtual work you do every day

We enable virtual work — offering over-time sessions where participants are more focused, insights are more diverse and business goals are met.

Webinar: Patient-Focused Drug Design: Through the Lens of Real-World Case Studies, Clinical Evidence and Advanced Delivery Solutions

Discover the current state of patient-focused dose design through clinical evidence, real-world case studies and patient preference-driven drug design solutions that can help develop better treatments and successful real-world outcomes.

eBook: Drug Design and the Patient Journey

This eBook features insights from experts in the industry on patient-centric drug development challenges and strategies on advancing drug design and development effectively.

eBrief: Drug Product Process Development: Ensuring a Consistent, High-quality Biologic

Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase.

Events